Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Country |
MMT |
Ref. |
HDBT |
Ref. |
Heroin assisted treatment |
Ref. |
|---|---|---|---|---|---|---|
Belgium |
1994 |
6 |
2003 |
2, 7 |
under study |
13 |
Czech Republic |
1998 |
4 |
2000 |
2 |
|
|
Denmark |
1970 |
1 |
1999 |
2 |
|
|
Germany |
1992 |
1 |
2000 |
2 |
2003 |
9 |
Estonia |
2001 |
3 |
2003 |
2 |
|
|
Greece |
1993 |
1 |
2002 |
14 |
|
|
Spain |
1990 |
1, 5 |
1996 |
16 |
2003 |
8 |
France |
1995 |
1 |
1996 |
2 |
|
|
Ireland |
1992 |
1 |
2002 |
8 |
|
|
Italy |
1975 |
1 |
1999 |
2 |
|
|
Latvia |
1996 |
3 |
2003 |
8 |
|
|
Lithuania |
1996 |
11 |
2002 |
2 |
|
|
Luxembourg |
1989 |
1 |
2002 |
2 |
|
|
Hungary |
1995 |
3 |
|
|
|
|
Malta |
1987 |
10 |
|
|
|
|
Netherlands |
1968 |
1 |
1999 |
2 |
1997 |
1 |
Austria |
1987 |
1 |
1999 |
2 |
|
|
Poland |
1993 |
3 |
|
|
|
|
Portugal |
1977 |
1 |
1999 |
2 |
|
|
Slovenia |
1990 |
3 |
2004 |
2, 8 |
|
|
Slovakia |
1997 |
11 |
1999 |
15 |
|
|
Finland |
1974 |
1 |
1997 |
2 |
|
|
Sweden |
1967 |
1 |
1999 |
2 |
|
|
United Kingdom |
1968 |
1 |
1999 |
2 |
1920s |
12 |
Bulgaria |
1996 |
11 |
|
|
|
|
Romania |
1998 |
3 |
|
|
|
|
Norway |
1998 |
8 |
2001 |
2 |
|
|
Notes: For MMT and HDBT, the dates reflect the official availability of the treatment. Where data are not available for a country, the table entry is left empty. Substitution treatment programmes are currently under preparation in Cyprus. Methadone is officially registered in Turkey for the treatment of opiate addiction, but information on availability of treatment is missing. See also 'General notes for interpreting data' on the Explanatory notes and help page. Sources: (1) Farrell F, Verster A, Davoli M, Nilson M and Merino PP (2000) Reviewing current practice in drug-substitution treatment in the European Union, EMCDDA Insights Series, No. 3, EMCDDA: Lisbon. (2) EMCDDA (2005) Annual Report 2005: selected issues. No. 3: Buprenorphine - treatment, misuse and prescription practices, Luxembourg: Office for Official Publications of the European Communities. (3) EMCDDA (2003) The State of the drugs problem in the acceding and candidate countries to the European Union, Luxembourg: Office for Official Publications of the European Communities. (4) A first unofficial programme was already implemented in 1992; see Czech Republic National Report 2000. (5) After introduction in 1983, methadone substitution was prohibited again between 1985 and 1990. (6) Following a National Consensus Conference, organised by the Ministry of Health in 1994. (7) Legal basis for HDBT treatment created in Belgium in 2004. (8) National Reports 2005. (9) Randomised controlled trial of heroin-assisted treatment (10) Arpa S, Muscat R (P-PG/Epid 2003 37E, p.30) (11) According to data on methadone consumption published by the INCB, see Table NSP-9. (12) Regular treatment option; prescribed in injectable and smokable form. United Kingdom National Report, 2005. (13) Heroin Delivery under Control: feasibility and follow-up study (DHCo), http://www.belspo.be/belspo/fedra/proj.asp?l=nl&COD=DR/10 (14) Personal communication, Manina Terzidou, 30 May 2006. (15) Buprenorphine was registered in the Slovakia in 1999; data on number of prescriptions not available. (16) Decreto 89/1996, of 4 June. | ||||||